MarketScreener Homepage > Equities > Xetra > Fresenius SE & Co. KGaA FRE DE0005785604

Report

Real-time Estimate Tradegate - 01/22 03:59:51 pm
38.175	EUR		-0.09%

01/19

Cytosorbents' CytoSorb Blood Purification Technology Gets Nod from South Korean Regulator

01/19

DGAP-DD : Fresenius SE & Co. KGaA english

01/18

FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Goldman Sachs maintains a Buy rating

Calendar

Upcoming events on FRESENIUS SE & CO. KGAA

02/24/21		FY 2020 Earnings Release (Projected)
05/06/21		Q1 2021 Earnings Release (Projected)
08/03/21		Interim 2021 Earnings Release (Projected)
11/04/21		Q3 2021 Earnings Release (Projected)

Past events on FRESENIUS SE & CO. KGAA

10/29/20 \| 07:30am		Q3 2020 Earnings Call
10/29/20		Q3 2020 Earnings Release
08/31/20		Ex-dividend day for final dividend
08/28/20 \| 04:00am		Annual General Meeting

Upcoming sector events for FRESENIUS SE & CO. KGAA

01/26/21		ENCOMPASS HEALTH CORPORATION : FY 2020 Earnings Release
01/27/21 \| 09:00am		ENCOMPASS HEALTH CORPORATION : FY 2020 Earnings Call
02/02/21		HCA HEALTHCARE, INC. : FY 2020 Earnings Release
02/02/21 \| 10:00am		HCA HEALTHCARE, INC. : FY 2020 Earnings Call

More events

Past sector events for FRESENIUS SE & CO. KGAA

01/13/21 \| 03:40pm		AMEDISYS, INC. : JP Morgan Healthcare Conference
01/13/21 \| 12:45pm		CVS HEALTH CORPORATION : JP Morgan Healthcare Conference - Panel
01/13/21 \| 11:40am		LHC GROUP, INC. : JP Morgan Healthcare Conference
01/12/21 \| 10:00am		TENET HEALTHCARE CORPORATION : JP Morgan Healthcare Conference

Annual publications

Annual results		2015	2016	2017	2018	2019	2020 (e)
Sales M €	Released Forecast Spread	27 626 27 709 -0,30%	29 083 29 129 -0,16%	33 886 34 031 -0,43%	33 530 33 367 0,49%	35 409 35 359 0,14%	36 285
Operating income (EBITDA) M €	Released Forecast Spread	5 073 5 053 0,40%	5 500 5 515 -0,27%	6 327 6 285 0,67%	6 681 6 227 7,3%	7 104 6 992 1,6%	7 009
Operating profit (EBIT) M €	Released Forecast Spread	3 958 3 960 -0,06%	4 327 4 332 -0,11%	4 890 4 857 0,69%	4 561 4 723 -3,4%	4 599 4 588 0,23%	4 615
Pre-Tax Profit (EBT) M €	Released Forecast Spread	3 262 3 311 -1,5%	3 745 3 725 0,54%	3 938 4 187 -5,9%	4 664 4 469 4,4%	3 912 3 889 0,60%	3 854
Net income M €	Released Forecast Spread	1 358 1 394 -2,6%	1 593 1 601 -0,52%	1 814 1 834 -1,1%	2 027 1 972 2,8%	1 883 1 823 3,3%	1 792
EPS €	Released Forecast Spread	2,48 2,58 -3,8%	2,90 2,92 -0,80%	3,25 3,32 -2,2%	3,63 3,55 2,3%	3,38 3,34 1,2%	3,19
Announcement Date		02/24/2016	02/22/2017	02/26/2018	02/20/2019	02/20/2020

Quarterly publications

Previous period

Next period

Quarterly results		2016 S1	2017 S1	2018 Q2	2018 S1	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 S1	2020 Q3	2020 Q4 (e)	2021 Q1 (e)	2021 Q2 (e)
Sales M €	Released Forecast Spread	14 006 14 060 -0,39%	16 894 16 904 -0,06%	8 382 8 416 -0,41%	16 503 16 497 0,04%	8 192 8 229 -0,44%	8 835 8 658 2,0%	8 495 8 510 -0,17%	8 761 8 726 0,40%	8 842 8 697 1,7%	9 311 9 388 -0,82%	9 135 8 934 2,3%	8 920 9 013 -1,0%	18 055 18 050 0,03%	8 918 8 936 -0,21%	9 234	8 979	9 121
Operating income (EBITDA) M €	Released Forecast Spread			2 307 1 527 51%		1 392 1 541 -9,7%	1 597 1 644 -2,9%	1 481 1 462 1,3%				1 755	1 762 1 683 4,7%		1 729 1 739 -0,58%	1 873
Operating profit (EBIT) M €	Released Forecast Spread	2 010 1 996 0,68%	2 393 2 384 0,38%	1 145 1 135 0,89%	2 199 2 157 1,9%	1 112 1 143 -2,8%	1 250 1 263 -1,1%	1 111 1 071 3,7%	1 081 1 116 -3,1%	1 130 1 092 3,5%	1 277 1 244 2,6%	1 125 1 057 6,4%	1 123 1 070 4,9%	2 248	1 113 1 109 0,38%	1 197
Pre-Tax Profit (EBT) M €	Released Forecast Spread	1 719 1 698 1,2%	2 054 2 070 -0,77%	1 788 1 745 2,5%		897 979 -8,4%	1 092 1 156 -5,5%	931 939 -0,82%	939 949 -1,0%	957 925 3,5%	1 085 1 046 3,8%	943 867 8,7%	956 953 0,32%		959 1 006 -4,7%	1 004
Net income M €	Released Forecast Spread	755 729 3,6%	907 908 -0,11%	652 552 18%		419 436 -3,9%	516 496 4,0%	453 451 0,35%	471 455 3,5%	444 429 3,6%	515 480 7,3%	459 413 11%	411 381 7,9%		427 422 1,2%	391
EPS	Released Forecast Spread	1,37 1,35 1,7%	1,63 1,64 -0,61%	1,17 0,92 27%		0,75 0,79 -4,8%	0,92 0,89 3,3%	0,81 0,81 0,06%	0,85 0,81 4,4%	0,80 0,76 4,8%	0,92 0,86 6,4%	0,82 0,76 8,1%	0,74 0,70 5,2%	1,56	0,77 0,75 2,7%	0,82	0,81	0,89
Announcement Date		08/02/2016	08/01/2017	07/31/2018	07/31/2018	10/30/2018	02/20/2019	05/02/2019	07/30/2019	10/29/2019	02/20/2020	05/06/2020	07/30/2020	07/30/2020	10/29/2020

Analysis

Italy looks to safeguard biomedical valley leading fight against COVID-19